reports
Donegal Group Inc. Announces Quarterly Dividend
Donegal Group Inc. Announces Quarterly Dividend MARIETTA, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) reported today that its board of directors declared a regular quarterly cash dividend of $0.1825 per share of the Company’s Class A common stock and $0.165 per share of the Company’s Class B common stock. The dividends are payable on February 17, 2026 to stockholders of record as of the close of business on February 3, 2026. About Donegal Group Inc. Donegal Group Inc. is an insurance holding company whose insurance subsidiaries and affilia...
Synaptics Showcases Edge AI Innovations at CES 2026
Synaptics Showcases Edge AI Innovations at CES 2026 Featuring Synaptics Astra™, Veros™, and Multimodal Sensing SAN JOSE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced that it will showcase a broad portfolio of AI-native processing, sensing, and connectivity technologies at CES 2026. These solutions demonstrate how intelligence at the Edge transforms real-world applications across consumer, industrial, smart home, and enterprise markets.As global demand grows for devices that can interpret their environment, make context-aware decisions, and...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 3,600 shares of its common stock to three newly-hired employees, with a grant date of December 9, 2025 (the "Grant Date"). The restricted stock units were granted pu...
Synaptics Inc: 1 director
A director at Synaptics Inc sold 18,285 shares at 80.291USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, ...
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, December 2, 2025 and Wednesday, December 10, 2025 SAN JOSE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in upcoming investor conferences. Rahul Patel, President and Chief Executive Officer, will participate in UBS’ Global Technology and AI Conference 2025 on Tuesday, December 2, 2025Rahul Patel, President and Chief Executive Officer, and Ken Rizvi, CFO, will present at Barclays 23rd Annual Global Technology Conference on Wednesday, December 10, 2025 at ...
- Jonathan Moreland
STAA STAAR SURGICAL CO.
MYE MYERS INDUSTRIES INC.
KVHI KVH INDUSTRIES INC.
GOGO GOGO INC.
GLP GLOBAL PARTNERS LP
FAST FASTENAL COMPANY
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
CNS COHEN & STEERS INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
AP AMPCO-PITTSBURGH
KYN KAYNE ANDERSON MLP INVESTMENT CO.
ICHR ICHOR HOLDINGS LTD.
CELH CELSIUS HOLDINGS INC.
SONO SONOS
AEYE AUDIOEYE INC
AVTR AVANTOR
TELA INC.
UTZ TELA BIO
ACVA UTZ BRANDS INC (A)
NEXT ACV AUCTIONS INC.
EVLV NEXT CAPITAL
BHVN EVOLV TECHNOLOGIES HLDGS INC
VANI BIOHAVEN LTD
WEST VIVANI MEDICAL INC
SMRT WESTROCK COFFEE COMPANY LLC
GTE SMARTRENT INC
ET GRAN TIERRA ENERGY INC.
MNR ENERGY TRANSFER LP
CRVO MACH NATURAL RESOURCES LP
NCDL CERVOMED INC
SPRU NUVEEN CHURCHILL DIRECT LENDING CORP
MXF SPRUCE POWER HOLDING CORP
GF THE MEXICO FUND
HYMC INC.
BATRK THE NEW GERMANY FUND
GMRE INC.
ANNX HYCROFT MINING HOLDING CORPORATION
LIBERTY MEDIA CORP
GLOBAL MEDICAL REIT INC.
ANNEXIN PHARMACEUTICALS AB (PUBL)
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Co...
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 37th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 37th Annual Healthcare Conference at 2:30 pm ET on December 3rd, 2025. Interested parties can access the live and archived webcast at . About TELA Bio, In...
- Jonathan Moreland
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
KVHI KVH INDUSTRIES INC.
GLP GLOBAL PARTNERS LP
FOXF FOX FACTORY HOLDING CORP.
FLDM FLUIDIGM
ALG ALAMO GROUP INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
TREX TREX COMPANY INC.
ICHR ICHOR HOLDINGS LTD.
CELH CELSIUS HOLDINGS INC.
HFFG HF FOODS GROUP INC
AVTR AVANTOR
PGNY INC.
TELA PROGYNY
SMCI TELA BIO
MRVI SUPER MICRO COMPUTER
BLND INC.
BHVN MARAVAI LIFESCIENCES HOLDINGS
DRCT ETRACS DJ-UBS COMMODITY INDEX 2-4-6 BLEND
VANI BIOHAVEN LTD
GTE DIRECT DIGITAL HLDGS INC
GT VIVANI MEDICAL INC
CRVO GRAN TIERRA ENERGY INC.
NCDL GOODYEAR TIRE & RUBBER CO.
NEXT CERVOMED INC
CATX NUVEEN CHURCHILL DIRECT LENDING CORP
RMI NEXTSOURCE MATERIALS INC.
BATRK PERSPECTIVE THERAPEUTICS
GMRE INC.
RIVERNORTH OPPOR MUN INC FD INC
LIBERTY MEDIA CORP
GLOBAL MEDICAL REIT INC.
Middlefield Banc Corp. Announces 2025 Fourth-Quarter Cash Dividend Pay...
Middlefield Banc Corp. Announces 2025 Fourth-Quarter Cash Dividend Payment MIDDLEFIELD, Ohio, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.21 per common share. The 2025 fourth-quarter dividend is payable on December 12, 2025, to shareholders of record on November 28, 2025. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the Bank holding Company of The Middlefield Banking Company, with total assets of $1.98 billion at September 30, 202...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of (i) restricted stock units covering 30,200 shares of its common stock to seventeen newly-hired employees and (ii) an option to purchase 25,000 shares of its common stock to one employee, with a gra...
Synaptics to Participate at Upcoming Investor Conference Wednesday, No...
Synaptics to Participate at Upcoming Investor Conference Wednesday, November 19, 2025 SAN JOSE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in the upcoming investor conference. Ken Rizvi, Chief Financial Officer, will present at the Wells Fargo 9th Annual TMT Summit on Wednesday, November 19, 2025, at 1:30 PM PT. To view the webcast or access a replay, please visit About Synaptics Incorporated: Synaptics (Nasdaq: ) is driving innovation in AI at the Edge, bringing AI closer to end users and transforming how we engage wi...
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Di...
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 7,523,000 shares of common stock at an offering p...
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing ...
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Revenue of $20.7 million, a 9% increase from the third quarter of 2024Revised full year 2025 revenue guidance of at least 16% growth over full year 2024 Recent Strategic Highli...
Presurance Holdings Reports 2025 Third Quarter Financial Results
Presurance Holdings Reports 2025 Third Quarter Financial Results TROY, Mich., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Presurance Holdings, Inc. (Nasdaq: PRHI) (“Presurance” or the “Company”) today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Personal lines business combined ratio of 95.2%Net investment income of $1.3 millionBook value of $2.07 per common share outstanding Management Comments Brian Roney, CEO of Presurance, commented, "This past year has been one of transformation and re-definition. While the runoff of legacy com...
Synaptics and Qualcomm Partner to Advance Fingerprint and Touch Techno...
Synaptics and Qualcomm Partner to Advance Fingerprint and Touch Technology Across PC and Mobile Platforms Combining ecosystem expertise with advanced human-interface and sensing technologies, the engagement focuses on amplifying security and performance across AI PC and mobile platforms SAN JOSE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) and Qualcomm Technologies, Inc. have entered into a strategic engagement to focus on advancing Touch and Fingerprint Sensor Technology across the mobile and compute industry. By partnering, both companies expect to fur...
Synaptics Reports First Quarter Fiscal 2026 Results
Synaptics Reports First Quarter Fiscal 2026 Results Launched the next-generation of Astra multimodal GenAI processors to power the intelligent IoT edge Core IoT product sales increased 74 percent year-over-year Q1'26 Financial Results Revenue of $292.5 million, up 14% year-over-yearFiscal first quarter Core IoT product sales grew by 74% year-over-yearGAAP gross margin of 42.6%Non-GAAP gross margin of 53.2%GAAP loss per share of $0.53Non-GAAP diluted earnings per share of $1.09 SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Synaptics Incorporated (Nasdaq: ) today reported financi...
TELA Bio to Announce Third Quarter 2025 Financial Results
TELA Bio to Announce Third Quarter 2025 Financial Results MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report third quarter 2025 financial results on Thursday, November 13, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Third Quarter Earnings Conference Call and Webcast DetailsInve...
TELA Bio Appoints William Plovanic to Board of Directors
TELA Bio Appoints William Plovanic to Board of Directors MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (“Bill”) Plovanic, CFA, to its Board of Directors. Mr. Plovanic brings a distinctive combination of capital markets expertise and operational leadership in medical technology. He currently serves as Managing Director, Healthcare Equity ...
Donegal Group Inc. Announces Third Quarter and First Nine Months of 20...
Donegal Group Inc. Announces Third Quarter and First Nine Months of 2025 Results MARIETTA, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months of 2025. Significant Items for third quarter of 2025 (all comparisons to third quarter of 2024): Net premiums earned decreased 3.4% to $229.8 millionCombined ratio of 95.9%, compared to 96.4%Net income of $20.1 million, or 55 cents per diluted Class A share, compared to $16.8 million, or 51 cents per diluted Class A shareNet ...
American Assets Trust, Inc. Reports Third Quarter 2025 Financial Resul...
American Assets Trust, Inc. Reports Third Quarter 2025 Financial Results Net income available to common stockholders of $4.5 million and $52.5 million for the three and nine months ended September 30, 2025, respectively, or $0.07 and $0.87 per diluted share, respectively. Funds from Operations ("FFO") of $0.49 and $1.53 per diluted share for the three and nine months ended September 30, 2025, respectively. Increased 2025 FFO per diluted share guidance to a range of $1.93 to $2.01 with a midpoint of $1.97, a $0.02 increase over prior guidance. SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.